We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Biomarkers Identified for Early Detection of Colon Cancer

By LabMedica International staff writers
Posted on 22 Oct 2014
Print article
Bio-Rad Laboratories\'s Experion automated electrophoresis system
The Experion automated electrophoresis system (Photo courtesy of BIO-RAD LABORATORIES)
Colorectal cancer (CRC) is still one of the most frequent and deadly cancers world-wide in both women and men and the prevention of this disease is, therefore, a significant public health issue.

Aberrant cytokine signaling has been associated with many diseases, including several cancers, disorders in hematopoiesis and autoimmune diseases and cytokine responses have to be stringently controlled by a number of key regulatory proteins, such as the suppressors of cytokine signaling (SOCSs) family members.

Scientists at the University of Luxembourg (Luxembourg) and their colleagues collected primary colon cancer tissue and matched distant non-neoplastic colon tissue at the farthest longitudinal surgical margin from 66 CRC patients as well as 23 normal tissue samples matching the corresponding tumor samples. There were 35 males and 31 female with a median age of 67 years in the CRC cohort.

Laser microdissection (LMD) was used to maximize the purity of the epithelial tumor cell population. Ribonucleic acid (RNA)/DNA extraction was performed using commercially available kits and real-time polymerase chain reaction (PCR) assays were performed using TaqMan technology (Applied Biosystems; Foster City, CA, USA). RNA quality was checked by the Experion automated electrophoresis system (Bio-Rad Laboratories; Hercules, CA, USA) and RNA quality from all primary samples was of average quality. For the monitoring of the methylation pattern of the SOCS2 promoter, pyrosequencing and MassARRAY technology was performed (Sequenom; San Diego, CA, USA). Western blots and immunohistochemical analysis was also performed.

The scientists found that in colorectal cancer the amount of two SOCS proteins (SOCS2 and SOCS6) was reduced compared to healthy colon tissue. This suggests that testing for the quantity of these two proteins may be useful in the diagnosis of colorectal cancer. In addition, they found a link between the amount of SOCS2 in early stage colorectal cancer and patients' prognosis. They also discovered that in approximately 25% of the cancer tissues the activation of the SOCS2 gene was blocked. Hence, the gene could not be efficiently activated, and normal amounts of the corresponding SOCS2 protein could not be produced.

The authors concluded that a significantly higher disease-free survival time was observed in patients with high compared to low SOCS2 expression in early CRC stages (stages I and II). Together, their findings imply that SOCS proteins play a role in preventing colon cancer and can be used as biomarkers to distinguish healthy from cancerous colon tissue. It is a very promising first step, which could ultimately lead to the development of a new early diagnostic test for colorectal cancer. The study was published on August 12, 2014, in the British Journal of Cancer.

Related Links:

University of Luxembourg
Bio-Rad Laboratories


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.